Heinz Leibl

Title: Innovations by Heinz Leibl in Subcutaneous Administration of Immune Globulin

Introduction

Heinz Leibl is a notable inventor based in Pechtoldsdorf, Austria. He has made significant contributions to the field of medicine, particularly in the administration of immune globulin. His work focuses on improving treatment methods for diseases that can be addressed with immune globulin therapy.

Latest Patents

Heinz Leibl holds a patent for "Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase." This patent provides combinations, compositions, and kits that contain an immune globulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration. Such products can be utilized in methods of treating IG-treatable diseases or conditions. Additionally, the patent outlines methods for subcutaneous administration of immune globulin, ensuring that the dosing regimen is substantially the same as for intravenous administration of the same dosage for the treatment of the same IG-treatable disease or condition.

Career Highlights

Heinz Leibl is associated with Takeda Pharmaceutical Company Limited, where he continues to contribute to advancements in pharmaceutical innovations. His work is pivotal in enhancing the efficacy and convenience of immune globulin therapies.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Heinz Leibl's innovative work in the field of immune globulin administration represents a significant advancement in medical treatment options. His contributions are vital for improving patient care and treatment outcomes.